Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MGX is expected to report earnings to rise 48.15% to -80 cents per share on November 12
Q3'25
Est.
$-0.80
Q2'25
Beat
by $0.18
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.40
Q3'24
Beat
by $0.24
The last earnings report on August 12 showed earnings per share of -54 cents, beating the estimate of -72 cents. With 103.74K shares outstanding, the current market capitalization sits at 68.69M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MGX showed earnings on August 12, 2025. You can read more about the earnings report here.